Pharmafile Logo
Pharmafocus logo
Advanced Search

Drug regulators protect profits over patients, new study finds

May 11, 2011
Research and Development Bad Science, Vioxx, regulatory affairs

Medicine regulators are protecting drug company profits over the welfare of patients by withholding trial data. That’s the verdict of …

News
Novo Nordisk headquarters

New product can overtake Lantus, says Novo leader

May 11, 2011
Sales and Marketing Novo Nordisk, degludec, diabetes, insulin

Novo Nordisk’s new insulin product can eclipse Sanofi’s Lantus within just a few years of its launch, according to Novo’s …

News

Verdict on AMT’s gene therapy expected soon

May 11, 2011
Research and Development, Sales and Marketing AMT, Amsterdam Molecular Therapeutics, gene therapy, genes

Amsterdam Molecular Therapeutics says it will shortly receive the regulatory verdict on its gene therapy Glybera. Glybera (alipogene tiparvovec) is …

News
Blog footer

Digital Pharma: NICE puts guidance into online pathways

May 11, 2011
Sales and Marketing Digital Pharma blog, NICE

NICE has launched a new online tool that groups its guidance into user-friendly flowcharts to show care pathways. NICE Pathways …

News

Service Insight: Clinical trials – managing route to market

May 11, 2011
Research and Development Service Insight, Talking Point, research and development

SERVICE INSIGHT Clinical trials are notoriously difficult to manage and often fraught with problems, as they can involve many clinical …

Feature

Pfizer drops early-stage asthma candidate

May 11, 2011
Research and Development Pfizer, Rigel, asthma

Pfizer has returned the rights to a phase I asthma candidate to Rigel Pharmaceuticals. San Francisco-based Rigel says Pfizer is …

News

Wave Healthcare appoints former BMS medical liaison manager

May 11, 2011
Medical Communications appointment, medical communications

Buckinghamshire-based med comms agency Wave Healthcare has appointed five new members of staff, including a former senior medical liaison manager …

News
Elan manufacturing

Elan sells formulations unit to Alkermes for $960m

May 10, 2011
Manufacturing and Production Alkermes, Elan

Irish drugmaker Elan has finally found a buyer for its Elan Drug Technologies unit, which has been on and off …

News
Bayer

FDA fast-tracks Bayer’s GIST drug regorafenib

May 10, 2011
Sales and Marketing Bayer, GIST, regorafenib

The assessment of Bayer HealthCare’s investigational drug regorafenib is to be fast-tracked by US authorities for the treatment of stomach …

News
Networks in Health

Digital Pharma: European doctors’ communities form major alliance

May 10, 2011
Medical Communications Coliquio, Digital Pharma blog, Doctors.net.uk, Egora, Medcenter, doctors' social networks, meduniverse, online doctors communities

Europe’s largest online doctors communities have formed an alliance that could help pharma break through the language barrier to engage …

News
Merck Pharmaceutical Manufacturing (MPM)

Merck KGaA sells South African manufacturing unit

May 10, 2011
Manufacturing and Production Merck KGaA, Merck Pharmaceutical Manufacturing, Merck South Africa

Merck South Africa, a subsidiary of Germany’s Merck KGaA, has sold its manufacturing to a local private equity firm as …

News
frontera_frank_walters

Frank Walters joins Frontera as chairman

May 10, 2011
Medical Communications appointment, medical communications

Healthcare comms start-up Frontera London has appointed industry veteran Frank Walters as its non-executive chairman. Frank was previously creative director …

Appointment

Generic and API firms get latest crop of FDA warning letters

May 10, 2011
Manufacturing and Production Cephazone, FDA, FDA warning letter, Ningbo Smart, Teva

Generic drugmakers Teva and Cephazone and API producer Ningbo Smart are the latest companies to receive warning letters from the …

News

French pharma firm denies drug risk cover up

May 10, 2011
Sales and Marketing Mediator, Servier, drug safety

France’s second biggest pharma firm Servier has denied allegations it concealed risks associated with its diabetes drug Mediator (benfluorex). Research …

News
Sanofi's new logo

Sanofi name change sees Aventis dropped

May 9, 2011
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Sanofi-Aventis

Sanofi-Aventis will now just be known as Sanofi after the French pharma company’s shareholders agreed to change its name. Following …

News

Alliance warns of ‘dumbing down’ of NHS reforms

May 9, 2011
NHS reforms

The leader of the NHS Alliance has warned the current ‘pause’ in the NHS reforms could result changes which ‘dumb …

News
Pfizer

Pfizer’s Revatio extends Europe PAH licence

May 9, 2011
Sales and Marketing PAH, Pfizer, pulmonary arterial hypertension, revatio

Pfizer’s Revatio has been approved by European regulators for the treatment of pulmonary arterial hypertension (PAH) in children.The European Commission has …

News

Pharma manufacturing news in brief

May 9, 2011
Manufacturing and Production

This week’s roundup has new contract awards for Aptuit and SAFC, plus facility updates from Cangene, Carbogen-Amcis and Aanjaneya Lifecare. …

News
Sanofi headquarters

Sanofi abandons $375m oral diabetes deal

May 9, 2011
Sales and Marketing Metabolex, Sanofi, diabetes

Sanofi has terminated its $375 million deal with US biotech Metabolex to develop a novel oral anti-diabetic treatment. The French …

News
Pfizer

Pfizer signs Chinese commercial collaboration

May 9, 2011
Sales and Marketing China, Pfizer, Shanghai Pharmaceutical Co

US giant Pfizer looks set to collaborate with Shanghai Pharmaceutical Co. on business opportunities in China. The potential partnership is …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026